Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy

FRIDAY, Sept. 1, 2023 -- Rates of rifaximin treatment retention are low despite the known benefits of rifaximin use for breakthrough hepatic encephalopathy (HE), according to a study published in the August issue of Hepatology...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news